These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
210 related articles for article (PubMed ID: 28614959)
1. The effects of triptolide on the pharmacokinetics of sorafenib in rats and its potential mechanism. Wang X; Zhang X; Liu F; Wang M; Qin S Pharm Biol; 2017 Dec; 55(1):1863-1867. PubMed ID: 28614959 [TBL] [Abstract][Full Text] [Related]
2. Effects of puerarin on the pharmacokinetics of triptolide in rats. Wang Q; Wu Y; Xiang F; Feng Y; Li Z; Ding Y Pharm Biol; 2019 Dec; 57(1):407-411. PubMed ID: 31230510 [No Abstract] [Full Text] [Related]
3. Effects of triptolide on pharmacokinetics of fenofibrate in rats and its potential mechanism. Li T; Liu J; Zheng Y; Yang S; Liu X; Li X Xenobiotica; 2019 Feb; 49(2):211-215. PubMed ID: 29412757 [TBL] [Abstract][Full Text] [Related]
4. Effects of triptolide on the pharmacokinetics of cyclophosphamide in rats: a possible role of cytochrome P3A4 inhibition. Zhang XF; Liu J; Ye F; Ji SG; Zhang N; Cao RS; He L; Wu JC; Li XF Chin J Integr Med; 2014 Jul; 20(7):534-9. PubMed ID: 24420925 [TBL] [Abstract][Full Text] [Related]
5. No Effect of Levothyroxine and Levothyroxine-Induced Subclinical Thyrotoxicosis on the Pharmacokinetics of Sorafenib in Healthy Male Subjects. Huang F; Ajavon A; Huang E; Lettieri J; Liu R; Peña C; Berse M Thyroid; 2017 Sep; 27(9):1118-1127. PubMed ID: 28741453 [TBL] [Abstract][Full Text] [Related]
6. Sorafenib metabolism, transport, and enterohepatic recycling: physiologically based modeling and simulation in mice. Edginton AN; Zimmerman EI; Vasilyeva A; Baker SD; Panetta JC Cancer Chemother Pharmacol; 2016 May; 77(5):1039-52. PubMed ID: 27053087 [TBL] [Abstract][Full Text] [Related]
7. Influence of grapefruit juice on pharmacokinetics of triptolide in rats grapefruit juice on the effects of triptolide. Jia Y; Liu J; Xu J Xenobiotica; 2018 Apr; 48(4):407-411. PubMed ID: 28359180 [TBL] [Abstract][Full Text] [Related]
8. Differential effects of hepatic cirrhosis on the intrinsic clearances of sorafenib and imatinib by CYPs in human liver. Murray M; Gillani TB; Ghassabian S; Edwards RJ; Rawling T Eur J Pharm Sci; 2018 Mar; 114():55-63. PubMed ID: 29223619 [TBL] [Abstract][Full Text] [Related]
9. Enhanced oral absorption of sorafenib via the layer-by-layer deposition of a pH-sensitive polymer and glycol chitosan on the liposome. Zhao M; Lee SH; Song JG; Kim HY; Han HK Int J Pharm; 2018 Jun; 544(1):14-20. PubMed ID: 29655795 [TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetic study of conventional sorafenib chemoembolization in a rabbit VX2 liver tumor model. Parvinian A; Casadaban LC; Hauck ZZ; van Breemen RB; Gaba RC Diagn Interv Radiol; 2015; 21(3):235-40. PubMed ID: 25835078 [TBL] [Abstract][Full Text] [Related]
11. Use of transgenic mouse models to understand the oral disposition and drug-drug interaction potential of cobimetinib, a MEK inhibitor. Choo EF; Woolsey S; DeMent K; Ly J; Messick K; Qin A; Takahashi R Drug Metab Dispos; 2015 Jun; 43(6):864-9. PubMed ID: 25813936 [TBL] [Abstract][Full Text] [Related]
12. Effects of triptolide on pharmacokinetics of amlodipine in rats by using LC-MS/MS. Zhang C; Gao Z; Niu L; Chen X Pharm Biol; 2018 Dec; 56(1):132-137. PubMed ID: 29385884 [TBL] [Abstract][Full Text] [Related]
13. Absorption and Metabolism Characteristics of Triptolide as Determined by a Sensitive and Reliable LC-MS/MS Method. Gong X; Chen Y; Wu Y Molecules; 2015 May; 20(5):8928-40. PubMed ID: 25993421 [TBL] [Abstract][Full Text] [Related]
14. Herb-Drug Interaction between the Traditional Hepatoprotective Formulation and Sorafenib on Hepatotoxicity, Histopathology and Pharmacokinetics in Rats. Ting CT; Cheng YY; Tsai TH Molecules; 2017 Jun; 22(7):. PubMed ID: 28640225 [TBL] [Abstract][Full Text] [Related]
15. Biological evaluation of a novel sorafenib analogue, t-CUPM. Wecksler AT; Hwang SH; Liu JY; Wettersten HI; Morisseau C; Wu J; Weiss RH; Hammock BD Cancer Chemother Pharmacol; 2015 Jan; 75(1):161-71. PubMed ID: 25413440 [TBL] [Abstract][Full Text] [Related]
16. Effects of glycyrrhizin on the pharmacokinetics of nobiletin in rats and its potential mechanism. Wang H; Dong L; Qu F; He H; Sun W; Man Y; Jiang H Pharm Biol; 2020 Dec; 58(1):352-356. PubMed ID: 32298152 [No Abstract] [Full Text] [Related]
17. Effects of glycyrrhizin on the pharmacokinetics of paeoniflorin in rats and its potential mechanism. Sun H; Wang J; Lv J Pharm Biol; 2019 Dec; 57(1):550-554. PubMed ID: 31429612 [No Abstract] [Full Text] [Related]
18. Ontogeny and sorafenib metabolism. Zimmerman EI; Roberts JL; Li L; Finkelstein D; Gibson A; Chaudhry AS; Schuetz EG; Rubnitz JE; Inaba H; Baker SD Clin Cancer Res; 2012 Oct; 18(20):5788-95. PubMed ID: 22927483 [TBL] [Abstract][Full Text] [Related]
19. Sorafenib and sunitinib, two anticancer drugs, inhibit CYP3A4-mediated and activate CY3A5-mediated midazolam 1'-hydroxylation. Sugiyama M; Fujita K; Murayama N; Akiyama Y; Yamazaki H; Sasaki Y Drug Metab Dispos; 2011 May; 39(5):757-62. PubMed ID: 21266595 [TBL] [Abstract][Full Text] [Related]
20. Inhibitory Effects of Triptolide on Human Liver Cytochrome P450 Enzymes and P-Glycoprotein. Zhang H; Ya G; Rui H Eur J Drug Metab Pharmacokinet; 2017 Feb; 42(1):89-98. PubMed ID: 26874845 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]